The current edition of the British Journal of Psychiatry, May 2018, contains academic papers on depressive disorders. In this post I will share some of the declarations of interest linked … Continue reading The British Journal of Psychiatry: are competing interests of authors sufficiently transparent?
The following is a PMCPA (Prescription Medicines Code of Practice Authority) Case Ruling on Latuda promotion from July 2016. Sunovion were found to have breached Clauses 8.2 and 9.1 Page … Continue reading Latuda promotion “high standards had not been maintained”
With careful thought, and backed with full supporting evidence, I sent the following letter of the 2nd February 2016 to support my petition for a Sunshine Act for Scotland. The Senior Clerk … Continue reading A letter that the Scottish Parliament felt unable to publish
I have recently posted on the promotion of Lurasidone (Latuda) in the UK. This has raised concerns for me about transparency of conflicts of interest for some of the key … Continue reading “A robust learning environment for healthcare professionals”